| Ytd | -0.13% | |
| 1y | 8.17% |
| Open | 1404.82 | Prev Close | 1410.44 | Low | 1385.12 | High | 1409.71 | Mkt Cap | 27.90B |
| Vol | 544.38K | Avg Vol | 197.41K | EPS | 44.42 | P/E | 31.34 | Forward P/E | 26.95 |
| Beta | 1.22 | Short Ratio | 3.60 | Inst. Own | 105.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1369.61 | 200-d Avg | 1314.11 | 1yr Est | 1452.50 |
MTD News
Mettler-Toledo Intl (NYSE:MTD) has outperformed the market over the past 20 years by 7.54% on an ann
Bank of America Corp DE purchased a new position in shares of Mettler-Toledo International, Inc. (NY
Rothschild & Co analyst Natalya Davies initiates coverage on Mettler-Toledo Intl (NYSE:MTD) w
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
RBC Capital analyst Dan Leonard initiates coverage on Mettler-Toledo Intl (NYSE:MTD) with a Secto
Richard Brennan, co-author of the forthcoming Trend Following Manifesto, argues that trend following
Mettler-Toledo International Inc. stock (ISIN US5926881054) has delivered a strong weekly gain of 7.
The acquisition would strengthen GE HealthCare’s pharmaceutical diagnostics segment by expanding its